March 16, 2020 / 12:48 PM / 13 days ago

BRIEF-Fusen Pharmaceutical Company Sees Decrease In Profit Attributable For Fy2019 By Over 45%

March 16 (Reuters) - Fusen Pharmaceutical Company Ltd :

* EXPECTED TO RECORD A DECREASE IN PROFIT ATTRIBUTABLE FOR FY2019 BY OVER 45%

* EXPECTED RESULT DUE TO INCREASED INVESTMENTS IN RESEARCH AND DEVELOPMENT, AMONG OTHER THINGS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below